MedTrace Logo

Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®

NCT00929071 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-08-07

Study results available
· View outcomes & findings →

Summary

The study doctor will give EVOLENCE® mixed with Lidocaine to people in this study to see if it effectively reduces pain while injecting and works to correct nasolabial wrinkles.

The product being used in this study is EVOLENCE®, which is currently marketed in the United States for the cosmetic correction of soft tissue contour deficiencies (including wrinkles), and been approved by the U.S. Food and Drug Administration (FDA).

Conditions

Interventions

DEVICE

Evolence

Injectable collagen

DEVICE

Lidocaine

admix anesthetic

DRUG

topical anesthetic

Sponsors & Collaborators

  • Weinkle, Susan H., M.D.

    lead INDIV

Principal Investigators

  • Susan Weinkle, MD · Private Practice

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-01-31
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00929071 on ClinicalTrials.gov